From Red Book Online, download PowerPoint presentation slides based on Committee on Infectious Diseases (COID) policy statements as well as other key infectious disease content from AAP.

• Cochlear Implants
  • Table 1: Acute Otitis Media in Children With Cochlear Implants
• Immunization Schedules, 2012
  • Recommended Immunization Schedule for Persons Aged 0 Through 6 Years
  • Recommended Immunization Schedule for Persons Aged 7 Through 18 Years
  • Catchup Immunization Schedule for Persons Aged 4 Months Through 6 Years Who Start Late or Who Are More Than 1 Month Behind
  • Catchup Immunization Schedule for Persons Aged 7 Through 18 Years Who Start Late or Who Are More Than 1 Month Behind
• Influenza, 2011-12 Season — New!
  • Figure 1: Selected underlying medical conditions in patients hospitalized with influenza
  • Figure 2: World Health Organization vaccine composition recommendations 1986 to present
  • Figure 3: Number of 2011-2012 seasonal influenza vaccine doses for children 6 months through 8 years of age (Algorithm)
  • Figure 4: Percentage of children with titers greater than 1:32 during seasons with no change in vaccine antigen
  • Figure 5: Precautions for administering influenza vaccine to presumed egg-allergic recipients (Algorithm)
  • Table 1: Antiviral Drug Sensitivities of Influenza Strains Expected to Circulate During the 2011-2012 Influenza Season
  • Table 2: Recommended Trivalent Seasonal Influenza Vaccines for Different Age Groups: United States, 2011-2012 Influenza Season
  • Table 3: LAIV Compared With TIV
  • Table 4: Recommended Dosage and Schedule of Influenza Antiviral Medications for Treatment and Chemoprophylaxis for the 2011-2012 Influenza Season: United States
  • Table 5: Persons at Higher Risk Recommended for Antiviral Treatment for Suspected/Confirmed Influenza
• Rabies
  • Table 1: Rabies Postexposure Prophylaxis (PEP) Schedule
• Respiratory Syncytial Virus
  • Table 1: Palivizumab Prophylaxis for Infants and Young Children With CLD or CHD
  • Table 2: Maximum Number of Monthly Doses of Palivizumab for RSV Prophylaxis
  • Table 3: Maximum Number of Palivizumab Doses for RSV Prophylaxis of Preterm Infants Without CLD
• Rotavirus
  • Table 1: Profiles of Rotavirus Vaccines Licensed in United States
  • Table 2: Performance of Rotavirus Vaccines Licensed in United States in Clinical Trials
  • Table 3: Recommended Schedule for Administration of Rotavirus Vaccine
• Streptococcus pneumoniae
  • Table 1: Underlying Medical Conditions That Are Indications for Pneumococcal Immunization Among Children, According to Risk Group
  • Table 2: Recommended Routine Immunization Schedule for PCV13 Among Infants and Children Who Have Not Received Previous Doses of PCV7 or PCV13, According to Age at First Dose
  • Table 3: Recommended Transition Schedule From PCV7 to PCV13 Vaccination Among Infants and Children, According to Number of Previous PCV7 Doses Received
• Well Water
  • Table 1: Relevant Chemicals in Well Water
  • Table 2: Pathogenic Microorganisms Found in Well Water
  • Appendix 1: Flowchar for Testing Well Water
  • Appendix 2: Well Water Tests, Recommended Frequency, and Approximate Costs
  • Technical Report Table 1: Most Common Pathogenic Microorganisms Found in Well Water
  • Technical Report Figure 3: Filters and particle sizes for water contaminants